According to reports, GileadSciences a top maker of HIV drugs will share its intellectual property...Plus hautGileadSciencesGrowing optimism for GileadSciences Inc.’s hepatitis C treatment, Sovaldi, vaulted shares of the...Agrandir PHOTO D'ARCHIVESBill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the...Open Collage in a new Window Email the Collage Loading...“The U.S. government released a quarter of its stockpiles of the drugs after declaring a national...Dr. Martin joined GileadSciences in 1990 and currently serves as Chairman of the Board of Directors...Open Collage in a new Window Email the Collage Loading...Mission Statement The mission of the GileadSciences Research Scholars Program in Cystic Fibrosis is...GileadSciencesJohn Milligan ’83Mission Statement The mission of the GileadSciences Research Scholars Program in Pulmonary Arterial...Login to post commentsOpen Collage in a new Window Email the Collage Loading...GradeComparte esta información por correo electrónicoImage 1 of / 2 Caption Close Image 1 of 2 Image 2 of 2 GileadSciences CEO joins billionaires' ranks...Exclusive: HCV Cure - Open Letter to GileadSciences Order: Reorder Duration: 2:51 Updated: 04 Jun...Dr. Michael Riordan GileadSciences founder, CEO Chairman interview 1994 Order: Reorder Duration: 3...Scott Lazerwith Father and Research Scientist II at GileadSciences “I really liked it but I love...0:43 John F. Milligan, PhD, President and Chief Operating Officer, GileadSciences, Inc. Published:...GileadSciences made $10 billion off its Hepatitis C drug last year. (David Paul...GileadSciences pioneered the initiative to make treatment of HIV more widely available for the poor...Sovaldi pills. Photo: Insomniac70. Used under Creative Commons licenseuEUðXV[hµÄÅVÌîñð²¾³¢Is GileadSciences, Inc. (GILD) Destined for Greatness?